Ekopak NV Overview
Ekopak is a small-cap Belgian industrial water specialist that designs, builds, finances and operates decentralised process-water and wastewater treatment installations for water-intensive industrial customers in food, chemicals, pharma, cosmetics, steel and energy. Its differentiating model is Water-as-a-Service (WaaS): containerised, modular units that convert alternative sources (rainwater, surface water, treated effluent) into process water under long-term "pay-by-the-drop" contracts, in which Ekopak retains ownership and operating responsibility. The 2023 acquisition of Global Water & Energy (GWE) added anaerobic and industrial wastewater engineering and a footprint in Southeast Asia and the Americas, doubling revenue and pushing roughly half of sales outside Europe. Group revenue reached EUR 51.1m in FY2025, but the company remains loss-making, carries net financial debt of roughly EUR 74–80m, operates under an auditor-flagged material going-concern uncertainty, and has been through a turbulent 18 months of leadership turnover, a regulatory investigation and the near-collapse of its flagship Waterkracht project.
Company's own description
In its 2026 press materials Ekopak describes itself as a Belgian company specialised in industrial water treatment and wastewater treatment, whose solutions allow industrial clients to reduce water consumption sustainably, reliably and profitably, purify their wastewater, decouple from the public water network and start circular water use. It emphasises modular water purification units that transform off-grid sources (rain-, surface- and/or wastewater) into cleaner water usable and reusable in client processes. The IFRS notes describe Ekopak as a responsible and sustainable supplier of mission-critical industrial process water to customers worldwide. [Source: 1H2026 press release; 1H2026 IFRS interim statements, note 1]
The Euronext issuer profile adds that solutions can be offered either as standalone design-build (with optional operate and/or maintain services) or as a WaaS package delivering an end-to-end solution under a long-term contract with per-volume pricing. [Source: Euronext issuer page]
Business model and revenue model
| Segment | Revenue logic | Recognition | FY2025 revenue (EUR Mn) | Share |
|---|---|---|---|---|
| Project Business | One-off design & build of process-water and wastewater treatment plants; ownership transfers to client | Over time, milestone-based (engineering & procurement → equipment/factory construction → siteworks → start-up & commissioning) | 36.6 | 71.6% |
| Recurring Business | Services, consumables, rentals, O&M, and WaaS (guaranteed minimum water volume of contractual quality over contract life) | Consumables and single services point-in-time; services and WaaS over time | 14.5 | 28.4% |
Since January 2025 (internal reporting) and September 2025 (organisational implementation), Ekopak reports two segments:
[Source: FY2025 audited segment note; 1H2026 note 5]
Revenue by product type (FY2025, EUR thousands): consumables 1,956; services 8,523; one-off projects 36,178; WaaS 4,460; total 51,117. (Note: the product-type "one-offs" line of 36,178 differs slightly from the Project Business segment revenue of 36,625 — a EUR 0.45m classification difference between the two disclosures; not reconciled by the company.) [Source: FY2025 results press release]
Mix characterisation: roughly 71% project/product (lumpy, milestone-driven, working-capital intensive), 17% services, 4% consumables and 9% WaaS/subscription-like in FY2025. In 1H2026 the recurring share rose to 40% (WaaS 4.4m, services 4.0m, consumables 1.1m of 23.5m), driven by the NWB Tilburg acquisition. There is no licensing revenue.
WaaS / DBFMO accounting. Ekopak judges that its DBFMO (design-build-finance-maintain-operate) WaaS contracts do not contain a lease under IFRS 16, because it retains substantive substitution rights and the customer cannot direct the asset's use; the contracts are therefore accounted for under IFRS 15. WaaS contracts contain a EUR 1 purchase option at the end of the non-cancellable term, but management assumes renewal on the same terms when setting asset useful lives. [Source: 1H2026 note 4.2 and 4.8]
Financing model shift (2026). Historically, WaaS assets were financed on balance sheet during construction and then monetised via sale-and-leaseback with financial institutions (carrying value of such assets EUR 13.5m at 30 June 2026). In January 2026 Ekopak signed a long-term partnership with an unnamed infrastructure fund to finance WaaS and Circeaulair installations through project companies that will not be consolidated, with Ekopak acting as EPC partner; a similar structure is being set up in Asia with regional investors. Management acknowledged this will lower consolidated EBITDA margins but argued it improves free cash flow and return on equity. As of 1H2026 no WaaS installations had yet been sold into the off-balance structure. [Source: FY2025 press release; 1H2026 press release; CB Insights news excerpt, 27 January 2026]
Value-chain position
Ekopak sits at the engineering/integration and asset-ownership layer of the industrial water value chain: it designs systems, procures membranes, pumps and components, assembles process-water installations in its own factory (wastewater plants are typically built on site, with siteworks often subcontracted but recognised gross as principal), commissions and then operates/maintains them. It does not manufacture core membrane technology. Its WaaS and Circeaulair models push it further downstream into utility-like water supply. [Source: 1H2026 note 4.3]
Customers and end-markets
The company states that it works only with customers in the chemical, pharmaceutical and food industries with outstanding credit ratings, and that historical credit losses have been very limited. Named customers/projects in disclosures include TotalEnergies (Grandpuits, France — first major French WaaS), ArcelorMittal (Belgium WaaS), Agristo (India project; also an NWB Tilburg user), Nexus W2V (waste-to-value, USA), a large US-based brewery (contract announced 1H2025), and the four NWB Tilburg anchor users (Agristo, Coca-Cola, Fujifilm, IFF). One customer group accounted for EUR 2.3m or 10% of 1H2026 revenue (13% in 1H2025) under contracts with a total value of EUR 47.2m. [Source: 1H2026 note 7.1; 1H2025 note 6.1; FY2025 press release; LinkedIn post re TotalEnergies]
Independent characterisation
Ekopak is best understood as a sub-scale, project-heavy industrial water engineering contractor attempting to transition into a capital-light, recurring-revenue water utility for industry. The strategic logic — water scarcity, rising tariffs and discharge rules pushing industrials toward reuse — is sound, and the GWE deal gave genuine international reach and wastewater competence. Execution, however, has been poor: revenue is volatile half-to-half, adjusted EBITDA has been negative for two consecutive full years, the balance sheet has been levered to fund WaaS assets and a large new headquarters, and the flagship Waterkracht project has become a credibility problem rather than an asset. The company is effectively dependent on continued support from its majority shareholder Alychlo.
Strategy
Stated strategy themes (2025 Integrated Annual Report and results releases)
Paraphrased themes: (i) two business pillars — one-off projects and recurring WaaS — with WaaS as the long-term value driver; (ii) a strategic shift to off-balance-sheet WaaS financing to enable scalable, capital-efficient growth while preserving shareholder value; (iii) being a "total solution" partner combining process water and wastewater after GWE; (iv) international expansion (Asia, Americas, India); (v) circular water at district scale (Circeaulair, Waterkracht, NextGen District); (vi) cost discipline and organisational streamlining.
Initiatives in the last 24 months
| Initiative | Date | Description / target | Status |
|---|---|---|---|
| Capital increase | May-2025 | EUR 15m at EUR 5.60 | Completed |
| Leadership renewal | May–Sep 2025 | New chair, CFO, CEO; Cockpit model | Partially reversed: CEO left Jul-2026, Cockpit abolished Sep-2026 |
| Business-unit reorganisation | Sep-2025 | Project vs Recurring BUs cutting across legal entities | Implemented |
| Cost rationalisation programme | Sep-2025 | "Substantial run-rate savings" (no number disclosed) | FTE down from 290 to 265 by Jun-2026 |
| Off-balance WaaS partnership | Jan-2026 | Infrastructure fund finances WaaS/Circeaulair via project companies; fund also sources projects | Signed; no transfers at 30-Jun-2026 |
| Asian off-balance structure | 2,026 | Similar vehicle with regional investors | In set-up |
| NWB Tilburg acquisition | Jan-2026 | First wastewater WaaS | Closed |
| India subsidiary | Jan-2026 | Local presence | Incorporated |
| Additional cost reductions | Sep-2026 | Right-size organisation (no target disclosed) | Announced |
| Capital search | Sep-2026 | New equity with financial adviser | Ongoing |
| Asset monetisation | Sep-2026 | Portfolio of water installations that can be monetised | Ongoing |
Medium-term targets
2028 target (reiterated 2 March 2026): revenue of at least EUR 140m and EBITDA of EUR 35–42m. [FY2025 PR]
2026 guidance: "significant" revenue growth vs 2025 with further improvement in operating EBITDA; WaaS revenue expected to double vs 2024. Reconfirmed 1 September 2026. [1H2026 PR]
Status of 2028 targets: KBC Securities noted that the 1H2026 release no longer repeated the 2028 ambitions. Analyst view: given FY2025 revenue of EUR 51m and negative EBITDA, the 2028 targets should be treated as effectively suspended.
Products & Services
Ekopak does not publish a priced product catalogue; pricing models are disclosed only at the business-model level. Technical specifications for individual units are not publicly disclosed in the sources reviewed.
Project Business offerings
| Offering | Description | Target customer | Launch / status | Pricing model |
|---|---|---|---|---|
| Containerised process-water installations | Modular, factory-built units that treat rain-, surface- or wastewater into process water (cooling, boiler feed, process use); typically housed in transportable containers connected to client tanks | Water-intensive plants in food, chemicals, pharma, cosmetics, paper | Core legacy product; ongoing | One-off design & build contract, milestone-billed |
| Industrial wastewater treatment plants (GWE heritage) | Design & build of wastewater plants, including anaerobic treatment (GWE founder pioneered modern anaerobic treatment) and waste-to-value/energy schemes | Food & beverage, agri-processing, breweries, industrial parks globally | Acquired Sep-2023 | One-off EPC contract, milestone-billed |
| Turnkey "total solution" projects | Combined process-water + wastewater scope; recent named projects: Agristo (India), Nexus W2V (USA), large US brewery | Multinationals' international sites | 2025–2026 backlog | EPC |
| EPC for off-balance WaaS/Circeaulair assets | From 2026, Ekopak acts as EPC partner building installations owned by infrastructure-fund project companies | Fund-owned asset companies | Partnership signed Jan-2026; no transfers yet at 30-Jun-2026 | EPC margin |
Recurring Business offerings
| Offering | Description | Target customer | Launch / status | Pricing model |
|---|---|---|---|---|
| Water-as-a-Service (WaaS) / DBFMO | Ekopak designs, builds, finances, maintains and operates the installation on the client site and contractually supplies a guaranteed minimum volume of water of contractual quality | Industrial sites wanting off-balance-sheet water supply | Flagship model; named WaaS sites include TotalEnergies Grandpuits (FR) and ArcelorMittal (BE); three new WaaS projects operational in 1H2025 | Long-term "pay-by-the-drop" volume pricing; EUR 1 purchase option at end of term |
| WaaS for wastewater — NWB Tilburg | Central private industrial wastewater plant on the Fujifilm site in Tilburg treating effluent of Agristo, Coca-Cola, Fujifilm and IFF; first wastewater application within WaaS | Industrial clusters | Acquired 1-Jan-2026; contributed EUR 2.17m revenue and EUR 0.52m EBITDA in 1H2026 | Service fees from four users |
| Circeaulair (circular water) | Converting effluent from Aquafin wastewater plants into industrial process water delivered by new pipeline networks to companies or business parks; executed through JV Circeaulair I (51%) | Business parks, industrial clusters in Flanders | Supplier agreement Jun-2023; projects delayed vs subsidy timeline | Long-term supply contracts within JV; Ekopak earns EPC and maintenance fees |
| Waterkracht (project initiative) | Repurposing c. 20 billion litres/year of Aquafin-treated Antwerp household wastewater into cooling water for Port of Antwerp industry; Ekopak to build and run the membrane plant; >EUR 100m direct and indirect investment | Port of Antwerp industrials | Launched 2022; EPICo II withdrew Feb-2026; excluded from FY2025 accounts; current status not publicly disclosed | Would have been long-term WaaS |
| NextGen District concession | Decentralised water supply concession in Antwerp's NextGen District, separate from Waterkracht | District occupants | Disclosed Sep-2024; status n/d | — |
| Services | Legionella prevention, disinfection, boiler-water treatment, corrosion control, maintenance and operation of client-owned installations; iSERV heritage | Installed base and third-party plants | Ongoing; FY2025 services revenue EUR 8.5m | Service contracts / call-outs |
| Consumables | Treatment chemicals and replacement parts | Installed base | Ongoing; FY2025 EUR 2.0m | Unit sales |
| Rentals and pilot installations | Rental containers and pilot units for trials and temporary supply | Clients testing reuse; emergencies | Ongoing; some financed via sale-and-leaseback | Rental fees |
| Remote monitoring platform | Cloud platform used to monitor service activities and installations (capitalised software) | Internal/installed base | In use | Bundled |
| WaaS Asia | Singapore JV (51%) to reduce water footprint of industrial customers across Asia; cooperation with Vyncke referenced in the 2025 annual report | Asian industrial sites | Established 2024; first contract signed by 1H2026, no revenue yet | WaaS |
Financial Narrative
Data basis. FY2024–FY2025 from audited consolidated statements in the FY2025 results release (FY2024 as restated).
Income statement
Revenue CAGR FY2021–FY2025: c. 46% p.a. (EUR 11.25m → EUR 51.1m), heavily acquisition-driven (iSERV 2021, H2O Production 2022, GWE September 2023). Organic growth is not disclosed.
Gross profit. Ekopak presents costs by nature and does not report gross profit. A proxy (revenue less purchases of materials) is shown below for the two audited years only; TipRanks' FY2021–FY2023 "gross profit" uses a different definition and is not comparable.
Adjusted EBITDA (company definition, before one-off/non-operating items):
FY2025 EBITDA adjustments (net -EUR 0.886m) include the EUR 1.83m gain on the Tielt HQ sale (partly offset by EUR 0.25m costs), a EUR 0.25m legal settlement, EUR 0.41m start-up costs of foreign business, EUR 0.085m CEO/CFO recruitment and EUR 0.037m severance. The removal of Waterkracht from the accounts reduced FY2025 EBITDA by EUR 1.646m in total (EUR 0.367m at adjusted EBITDA level, EUR 1.28m at EBITDA level). [Source: FY2025 PR; 1H2025/1H2026 note 5]
H1-2026 snapshot (unaudited): revenue EUR 23.5m (+9%); adjusted EBITDA -EUR 1.2m (-5% margin); EBITDA +EUR 3.4m (including EUR 4.96m NWB badwill); operating loss before badwill -EUR 6.9m; net loss -EUR 1.8m after EUR 2.0m deferred tax credit; EPS -EUR 0.10. [Source: 1H2026 interim statements]
Commentary on income-statement trends. The inflection point was 2024: revenue still grew strongly (on the restated basis +32%) but the cost base expanded faster — personnel costs rose from EUR 17.0m (2024) to EUR 20.8m (2025) and depreciation from EUR 8.4m to EUR 9.6m as the Deinze campus and WaaS assets came on stream. Financial costs rose from EUR 2.9m to EUR 4.0m as debt grew. The H2-2025 recovery (revenue EUR 29.4m, +95% YoY; adjusted EBITDA +EUR 0.36m) proved that the business can break even at a semi-annual run-rate near EUR 30m, but the reversion to EUR 23.5m in 1H2026 shows the volatility of milestone-based project recognition. Reported net losses are cushioned by deferred tax income (EUR 3.9m in FY2025), which depends on management's judgement that carried-forward losses (EUR 52.9m at June 2026) will be recovered.
Balance sheet
FY2023 year-end reference points: total equity EUR 53.517m; borrowings and leases EUR 42.957m; cash EUR 12.679m (from opening balances in the FY2024 statements). Full FY2021–FY2023 balance sheets are not publicly disclosed in the sources reviewed.
30 June 2026 (unaudited): total assets EUR 162.9m; cash EUR 5.5m; borrowings excl. leases EUR 79.1m (ST 29.3m, LT 49.7m); leases EUR 6.4m; net financial debt excl. leases EUR 73.5m (EUR 79.9m incl. leases — consistent with KBC Securities' "c. EUR 80m"); equity EUR 41.1m; solvency ratio 25%. Borrowing mix: investment credits EUR 41.7m, straight loans EUR 21.1m, client-project investment loans EUR 11.7m, subordinated shareholder loan EUR 4.4m (debt component of the April 2026 convertible), leases EUR 6.4m. [Source: 1H2026 note 16]
Data-quality flag: the non-GAAP note in the 1H2026 report labels 31 December 2024 balances (borrowings EUR 71.240m, cash EUR 9.706m, net debt EUR 61.534m, equity EUR 41.205m) as "31 December 2025". The correctly computed 31 December 2025 net financial debt excl. leases is EUR 68.7m.
Cash flow
H1-2026: OCF +EUR 0.76m (first positive half-year OCF in the period reviewed, helped by EUR 1.7m higher contract liabilities and EUR 2.1m lower receivables); capex EUR 1.4m; acquisition of NWB EUR 2.15m; net borrowings +EUR 3.4m; cash down EUR 2.0m to EUR 5.5m. [Source: 1H2026 cash flow statement]
Ratios
Notes: ROE/ROA on average balances (FY2023 equity 53.5m used for FY2024 average; FY2023 total assets not disclosed, so FY2024 ROA uses year-end assets). Net debt/EBITDA and interest coverage are not meaningful with negative EBITDA/EBIT and are shown for completeness only. Cash conversion cycle is not computable from disclosed data (cost of sales not reported); DSO on trade receivables was c. 101 days in FY2025 (14.2m / 51.1m x 365), unusually high against stated 30-day payment terms, partly reflecting year-end project billing.
Overall financial commentary. Ekopak's financial profile is that of a growth-stage company that has run ahead of its funding: it has consumed roughly EUR 51m of free cash flow in two years against EUR 15m of new equity, financing the balance through bank debt that the banks have now partly placed under a principal moratorium. Book equity has been held flat only by the 2025 capital increase. Goodwill and intangibles (EUR 47.5m) exceed total equity (EUR 42.2m), meaning tangible equity is negative. The auditor's going-concern emphasis paragraph, the 1H2026 disclosure that continuity depends on successful monetisation of assets, and the need for successive shareholder loans make liquidity the single most important analytical variable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment revenue (EUR Mn)
| Segment revenue (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Project Business | 35.454 | 36.625 |
Recurring Business | 12.183 | 14.492 |
Total revenue | 47.637 | 51.117 |
Segment growth and mix (%)
| Segment growth and mix (%) | FY2024 | FY2025 |
|---|---|---|
Project Business YoY growth | 0 | 3.3 |
Recurring Business YoY growth | 0 | 19.0 |
Project Business share of revenue | 74.4 | 71.6 |
Recurring Business share of revenue | 25.6 | 28.4 |
Results by Segment
| Segment metric (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Project Business adjusted EBITDA | -3.986 | -2.943 |
Recurring Business adjusted EBITDA | 0.036 | -0.477 |
Project Business EBITDA | -4.670 | -4.303 |
Recurring Business EBITDA | 0.036 | -0.003 |
Project Business operating result | -9.557 | -9.913 |
Recurring Business operating result | -3.503 | -4.029 |
Project Business pre-tax result | -10.789 | -12.361 |
Recurring Business pre-tax result | -4.715 | -5.021 |
Segment margins (%)
| Segment margins (%) | FY2024 | FY2025 |
|---|---|---|
Project Business adjusted EBITDA margin | -11.2 | -8.0 |
Recurring Business adjusted EBITDA margin | 0.3 | -3.3 |
Project Business pre-tax margin | -30.4 | -33.8 |
Recurring Business pre-tax margin | -38.7 | -34.6 |
Results by Segment (Half-Yearly)
| Segment metric (EUR Mn) | H1-2024 | H1-2025 | H1-2026 |
|---|---|---|---|
Project Business revenue | 26.941 | 15.498 | 14.073 |
Recurring Business revenue | 5.640 | 6.189 | 9.475 |
Total revenue | 32.581 | 21.687 | 23.549 |
Project Business adjusted EBITDA | 2.192 | -2.682 | -2.565 |
Recurring Business adjusted EBITDA | -0.184 | -1.099 | 1.355 |
Group adjusted EBITDA | 2.008 | -3.781 | -1.210 |
Project Business EBITDA | 1.955 | -2.321 | -2.832 |
Recurring Business EBITDA | -0.184 | -0.661 | 6.232 |
Group EBITDA | 1.771 | -2.982 | 3.400 |
Project Business pre-tax result | -0.446 | -5.773 | -6.908 |
Recurring Business pre-tax result | -2.043 | -3.172 | 3.219 |
Income statement (EUR Mn)
| Income statement (EUR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 11.25 | 17.71 | 36.03 | 47.637 | 51.117 |
EBITDA (reported) | 0.371 | -0.409 | 3.48 | -4.634 | -4.306 |
Operating income (EBIT) | -0.611 | -2.29 | -3.40 | -13.060 | -13.942 |
Pre-tax income | -0.748 | -2.52 | -4.00 | -15.504 | -17.383 |
Net income | -0.70 | -1.99 | -3.08 | -12.232 | -13.826 |
EPS basic (EUR) | -0.05 | -0.13 | -0.21 | -0.83 | -0.79 |
EPS diluted (EUR) | -0.05 | -0.13 | -0.21 | -0.83 | -0.79 |
Dividend per share (EUR) | 0 | 0 | 0 | 0 | 0 |
Margins (%)
| Margins (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
EBITDA margin | 3.3 | -2.3 | 9.7 | -9.7 | -8.4 |
Operating margin | -5.4 | -12.9 | -9.4 | -27.4 | -27.3 |
Net margin | -6.2 | -11.2 | -8.5 | -25.7 | -27.0 |
Growth (%)
| Growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Revenue YoY growth | 57.4 | 103.4 | 32.2 | 7.3 |
Gross margin proxy (EUR Mn)
| Gross margin proxy (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Revenue less purchases of materials | 18.536 | 22.074 |
Proxy gross margin (%) | 38.9 | 43.2 |
Adjusted EBITDA (EUR Mn)
| Adjusted EBITDA (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Adjusted EBITDA | -3.950 | -3.420 |
Adjusted EBITDA margin (%) | -8.3 | -6.7 |
Balance Sheet
| Balance sheet (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Total assets | 155.982 | 158.575 |
Cash and cash equivalents | 9.706 | 7.563 |
Short-term borrowings | 22.691 | 27.008 |
Long-term borrowings | 48.549 | 49.292 |
Lease liabilities (short + long) | 6.258 | 6.670 |
Total financial debt incl. leases | 77.498 | 82.970 |
Net financial debt excl. leases | 61.534 | 68.737 |
Net debt incl. leases | 67.792 | 75.407 |
Total equity | 41.205 | 42.220 |
Goodwill | 19.349 | 19.349 |
Intangible assets | 30.830 | 28.110 |
Goodwill and intangibles | 50.179 | 47.459 |
Current assets | 42.107 | 39.247 |
Current liabilities | 52.793 | 54.580 |
Working capital (current assets less current liabilities) | -10.686 | -15.333 |
Deferred tax assets | 6.913 | 10.895 |
Cash flow (EUR Mn)
| Cash flow (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
Operating cash flow | -3.940 | -8.896 |
Capex (PP&E + intangibles) | 27.164 | 10.934 |
Free cash flow (OCF less capex) | -31.104 | -19.830 |
Proceeds from disposals of PP&E | 0.133 | 3.692 |
Net new borrowings (proceeds less repayments, excl. leases) | 31.764 | 5.060 |
Equity raised (gross) | 0 | 15.000 |
Interest paid | 2.681 | 3.066 |
Dividends paid | 0 | 0 |
Share buybacks | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratios | FY2024 | FY2025 |
|---|---|---|
ROE (%) | -25.7 | -33.1 |
ROA (%) | -8.6 | -8.8 |
ROIC (%, NOPAT proxy = EBIT x 0.75 / avg equity + net debt) | -9.5 | -9.1 |
Current ratio (x) | 0.80 | 0.72 |
Debt/equity (x, incl. leases) | 1.88 | 1.97 |
Net debt/EBITDA (x) | -14.6 | -17.5 |
Interest coverage EBIT/financial costs (x) | -4.4 | -3.5 |
Asset turnover (x) | 0.34 | 0.33 |
Solvency ratio equity/total assets (%) | 26.4 | 26.6 |
Revenue by region (EUR Mn)
| Revenue by region (EUR Mn) | H1-2024 | H1-2025 | H1-2026 |
|---|---|---|---|
Belgium | 8.751 | 5.794 | 6.401 |
Rest of Europe | 9.798 | 5.797 | 6.380 |
APAC | 0.644 | 1.828 | 3.237 |
Africa | 1.050 | 0.778 | 0.549 |
Americas | 12.338 | 7.490 | 6.982 |
Total | 32.581 | 21.687 | 23.549 |
Regional YoY growth (%)
| Regional YoY growth (%) | H1-2025 | H1-2026 |
|---|---|---|
Belgium | -33.8 | 10.5 |
Rest of Europe | -40.8 | 10.1 |
APAC | 183.9 | 77.1 |
Africa | -25.9 | -29.4 |
Americas | -39.3 | -6.8 |
Total | -33.4 | 8.6 |
Regional share of revenue (%)
| Regional share of revenue (%) | H1-2024 | H1-2025 | H1-2026 |
|---|---|---|---|
Belgium | 26.9 | 26.7 | 27.2 |
Rest of Europe | 30.1 | 26.7 | 27.1 |
APAC | 2.0 | 8.4 | 13.7 |
Africa | 3.2 | 3.6 | 2.3 |
Americas | 37.9 | 34.5 | 29.6 |
Calendar-year share price return (%)
| Calendar-year share price return (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
EKOP total price return | -3.67 | 10.69 | -26.37 | -62.41 |
Period return (%) | Value | — | — | — |
2026 year-to-date (to 16-Oct-2026) | -54.7 | — | — | — |
1-year (to 2-Oct-2026) | -45.1 | — | — | — |
Since 31-Dec-2023 (proxy for ~3 years; derived from calendar returns) | -87 | — | — | — |
Since IPO at EUR 14.00 (31-Mar-2021) to EUR 2.40 | -83 | — | — | — |
52-week range (as of early Oct-2026) | EUR 2.755 – 6.60 | — | — | — |
Valuation Multiples
| Multiple | Ekopak | Source |
|---|---|---|
Market capitalisation | EUR 42.0m | MarketScreener / derived |
Enterprise value | c. EUR 115m | MarketScreener |
EV/Sales 2026e | 1.68x | MarketScreener consensus |
EV/Sales 2027e | 1.53x | MarketScreener |
P/E 2026e | -16x (n/m) | MarketScreener |
P/B (on 30-Jun-2026 equity EUR 41.1m) | 1.02x | derived |
EV/EBITDA | n/m (negative adjusted EBITDA) | — |
Dividend yield | 0% | — |
Analyst Ratings & Targets
| Broker | Date | Rating / target | Notes |
|---|---|---|---|
Berenberg | 17-Oct-2024 | Buy, EUR 28.00 | — |
Berenberg | 10-Jan-2025 | Buy, EUR 22.00 | Current status n/d |
Kepler Cheuvreux | Sep-2025 | Liquidity warning | Rating n/d |
KBC Securities | 02-Mar-2026 | Hold EUR 5.50 placed under review | — |
KBC Securities | 03-Aug-2026 | Hold, EUR 4.60 | — |
KBC Securities | 01-Sep-2026 | Rating and target withdrawn | Cited lack of portfolio update, infra-fund progress and liquidity |
Analyst Conclusions
Management guidance
-
FY2026: significant revenue growth vs FY2025 (EUR 51.1m), with further improvement in operating EBITDA; much stronger H2 expected as backlog moves into execution. WaaS revenue to double vs 2024 (i.e., to c. EUR 7–8m based on FY2024 WaaS levels; FY2024 full-year WaaS figure itself not disclosed in sources reviewed).
-
Medium term: 2028 targets (≥EUR 140m revenue, EUR 35–42m EBITDA) were reiterated in March 2026 but omitted in September 2026.
-
Consensus (MarketScreener-implied): EV/Sales of 1.68x 2026e on EV of EUR 115m implies 2026e revenue of c. EUR 68m and c. EUR 75m for 2027e — consensus is based on very thin coverage following KBC's withdrawal.
Bull case
-
H2 backlog conversion: with EUR 49m of project backlog and higher contract liabilities (EUR 16.3m at June 2026, up EUR 2.6m), a strong H2-2026 could repeat the H2-2025 pattern and deliver a positive full-year adjusted EBITDA.
-
Capital-light pivot works: first transfers of WaaS assets to the infrastructure-fund vehicle would crystallise EPC margins, release cash and validate the model, while the EUR 23m DBFMO asset base offers monetisation optionality.
-
Optionality at a distressed valuation: at c. 1.0x book and c. 0.8x FY2025 sales on market cap, any Waterkracht revival, Asian WaaS traction or strategic interest from a larger water group would be pure upside, with a committed billionaire-backed majority shareholder providing downside support.
Bear case
-
Highly dilutive recapitalisation: cash of EUR 5.5m, a bank moratorium and repeated shareholder loans point to an equity raise priced near or below EUR 2.40, materially diluting minorities.
-
Structural unprofitability: Project Business adjusted EBITDA has been negative in five of six reported half-years since H1-2024's peak; the cost base appears too large for a EUR 45–55m revenue business.
-
Governance and credibility deficit: the Waterkracht episode, the unresolved FSMA investigation, revenue reversals and three CEO regimes in 13 months may deter customers from signing 10–15 year WaaS contracts and investors from funding them.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing | What to watch |
|---|---|---|
| Capital raise / strategic investor | Q4-2026 – H1-2027 | Price, size, Alychlo participation, minority dilution |
| Permanent CEO appointment | By end-2026 | Profile (turnaround vs growth) |
| First off-balance WaaS asset transfer | 2026–2027 | Cash proceeds, EPC margin recognition |
| Waterkracht outcome | Post Aug-2026 | New partner or formal termination |
| FSMA investigation outcome | Unknown | Sanction, settlement or closure |
| FY2026 results | 1-Mar-2027 | Delivery of "significant growth", adjusted EBITDA sign, auditor opinion wording |
| NWB purchase-price allocation finalisation | By Jan-2027 | Badwill confirmation or reduction |
| Bank moratorium terms | Ongoing | Covenant resets, maturity extension |
| Cost-reduction quantification | H2-2026 | Run-rate savings vs EUR 20m+ personnel cost |
Concluding analyst verdict
Ekopak sits at an uncomfortable intersection of an attractive long-term theme and a fragile near-term balance sheet. The industrial water-reuse opportunity is real: water stress, tariffs and discharge rules are pushing European and Asian industrials toward decentralised, circular supply, and Ekopak's containerised units, WaaS contracting experience and GWE's wastewater pedigree give it legitimate credentials. The Recurring Business, now including NWB Tilburg, finally showed positive adjusted EBITDA in 1H2026, and the EUR 49m backlog provides genuine visibility for the second half.
But the investment case is currently dominated by financing rather than operations. Over FY2024–FY2025 the company burned roughly EUR 51m of free cash flow, its auditor has flagged a material going-concern uncertainty, cash stood at EUR 5.5m in June, and its four banks have agreed a principal moratorium while the majority shareholder lends successive subordinated tranches. Tangible equity is negative, the 2028 targets have quietly disappeared from the narrative, the flagship Waterkracht project has lost a key partner, an FSMA investigation into past disclosures remains open, and the company is on its third leadership configuration in just over a year. The off-balance infrastructure-fund partnership is the right strategic answer, but nine months after signing, no asset had been transferred.
At EUR 2.40 the market is pricing a high probability of a deeply dilutive recapitalisation. For minority investors, the risk/reward is asymmetric only if one has conviction that Alychlo will backstop a raise at a reasonable price and that the interim CEO can right-size the cost base quickly. Until there is evidence of (i) a completed equity solution, (ii) first off-balance WaaS transfers and (iii) a positive full-year adjusted EBITDA, the stock should be treated as a special-situation, high-risk turnaround rather than a growth investment in water. Stance: Speculative / Avoid for non-specialist mandates; monitor recapitalisation terms as the decisive catalyst.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Since | Background / notes |
|---|---|---|---|
Wim Messiaen (via CAMAT BV) | CEO ad interim | 3-Aug-2026 (mandate to end-2026) | Prior roles, education and age not disclosed in sources reviewed |
Geert Bossuyt (via BOSVAN BV) | CFO | Jun-2025 | Co-lender in April 2026 convertible loan; prior roles n/d |
Pieter Loose (via Chasqui BV) | Non-executive director (formerly founder-CEO, then Chief Strategy & Growth Officer) | Founder; CEO until Sep-2025; CSGO Sep-2025–Sep-2026; non-executive from Sep-2026 | Born 1983 per aggregator; Pilovan BV (25.5% holder) associated with founder; co-lender in April 2026 convertible |
Management team | Reporting to CEO (replacing "Cockpit") | Sep-2026 | Composition not publicly disclosed |
Board of Directors
| Name | Role | Notes |
|---|---|---|
Jos De Vuyst (via DEVUMA BV) | Chairman | Since May 2025 |
Pieter Loose (via Chasqui BV) | Non-executive director | Since Sep-2026 (previously executive) |
Directors' Remuneration
| Remuneration (EUR K) | H1-2024 | H1-2025 | H1-2026 |
|---|---|---|---|
Key management short-term benefits | 1,029 | 733 | 1,066 |
Key management post-employment benefits | 14 | 14 | 30 |
Key management total | 1,043 | 747 | 1,096 |
Board fees (H1) | 0 | 43 | 43 |
Major Shareholders
| Holder | Stake 30-Jun-2026 (%) | Notes |
|---|---|---|
Alychlo NV (Marc Coucke) | 57.6 | Majority since May 2025 capital raise; also lender (Apr-2026 convertible; up to EUR 5.639m Sep-2026 loan) |
Pilovan BV | 25.5 | Founder-related vehicle; sold 1,084,637 shares to Alychlo in May 2025 |
Free float | 16.9 | — |
Competitive Landscape
Key Competitors
| Competitor | Overlap with Ekopak | — | Relative positioning |
|---|---|---|---|
Veolia (Water Technologies) | Industrial process water, reuse, outsourced water services, mobile water | Group revenue c. EUR 45bn (FY2024) | Global leader; full-service BOO/BOT capability; far larger balance sheet |
Xylem (incl. Evoqua) | Industrial water treatment, outsourced water services (Evoqua "Water One") | c. USD 8.6bn (FY2024) | Strong US service-based outsourcing; direct WaaS-like competitor in Americas |
Ecolab (Nalco Water) | Industrial water chemistry, services, consumables | c. USD 15.7bn (FY2024) | Dominant in treatment chemicals/services overlapping Ekopak's services/consumables |
Kurita Water Industries | Industrial water, chemicals, "water as a service" contracts | c. JPY 390bn (FY2024) | Pioneer of outsourced industrial water supply, strong in APAC |
SUEZ (post-2022 SUEZ) | Water services, industrial water | — | Large utility/industrial services player in Europe |
Paques (Netherlands) | Anaerobic industrial wastewater treatment | Private; n/d | Direct competitor to GWE heritage in food/beverage anaerobic plants |
Ovivo | Industrial and municipal water equipment | — | Equipment-led competitor |
BWT | Water treatment, industrial and point-of-use | — | European equipment and service competitor |
Aquatech International | Industrial water reuse, ZLD, BOO models | Private; n/d | Reuse/ZLD specialist with BOO offerings |
Pentair / Culligan | Industrial filtration and treatment, rentals | — | Overlap in smaller-scale industrial and rental installations |
Local/regional integrators (e.g., BOSAQ, Owatec, ACQUA.ecologie, Spacedrip) | Circular water, modular reuse | Start-up scale | Niche competitors in modular circular water |
Competitor Detail
| Metric | Ekopak FY2025 |
|---|---|
Revenue | EUR 51.1m |
Revenue growth | 7.3% |
EBITDA margin | -8.4% |



